Therapeutic advances in hematology

Ther Adv Hematol ISSN 2040-6207 474 views

Indexed In

ncbi ulakbim sci

Publications

2

ULAKBİM MEP: NULL Ödeme: 3750 Yılı: 2020

Details

Abbreviated Name: ther adv hematol
ISSN: 2040-6207

Publications/Year

Top Clicked Bibliographies from Search

1

Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

2017 248 clicks

2

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia.

2022 92 clicks